| 000 | 01405 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516235403.0 | ||
| 264 | 0 | _c20150720 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a2210-7711 | ||
| 024 | 7 |
_a10.1007/s11096-014-0022-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhno, Yoshiyuki | |
| 245 | 0 | 0 |
_aPersistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacy _cDec 2014 |
||
| 300 |
_a1134-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAntiemetics _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aAprepitant |
| 650 | 0 | 4 |
_aDrug Interactions _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInternational Normalized Ratio _xtrends |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorpholines _xadverse effects |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 700 | 1 | _aYamada, Maiko | |
| 700 | 1 | _aYamaguchi, Ryo | |
| 700 | 1 | _aHisaka, Akihiro | |
| 700 | 1 | _aSuzuki, Hiroshi | |
| 773 | 0 |
_tInternational journal of clinical pharmacy _gvol. 36 _gno. 6 _gp. 1134-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11096-014-0022-y _zAvailable from publisher's website |
| 999 |
_c24253637 _d24253637 |
||